Week In Review Three currents ran through longevity science this week. The Alzheimer’s Association International Conference (AAIC) opened in London on July 12, and the science it produced was strikingly practical: a 214,000-person analysis showing that dementia risk factors vary sharply by country, subcutaneous autoinjector data for lecanemab
Week In Review The past week produced a striking symmetry between two ends of the human-AI interface. On the invasive end, Neuralink disclosed a new transdural surgery that leaves the brain’s protective outer membrane intact, and CNBC reported that Chinese competitor BrainCo is betting on a very different theory
Week In Review The week’s biggest news was concentrated on Wednesday, July 9, when OpenAI’s GPT-5.6 lineup went to general availability and ChatGPT Work shipped as a merged desktop app pulling Codex into the same window as Chat. The bundle is best read as one product bet
Week In Review This week’s robotics news is dominated by two convergent themes: humanoid platforms are graduating from stage demonstrations into consequential deployments, and dexterity has become the industry’s central technical bet. The most substantive development is a UC San Diego group publishing the first live surgeries performed
Week In Review This week made a strong case that the “reusable rocket” era is no longer a one-country story. On July 10 China’s Long March 10B stuck a first-stage recovery on its maiden flight, becoming only the second nation to routinely recover an orbital-class booster, as covered in
Week In Review Independence week delivered exactly the kind of story that used to sound like a slide-deck fantasy: on July 4, Aalo Atomics’ critical test reactor went critical, becoming the fourth reactor authorized under the White House’s accelerated advanced-reactor program to reach that milestone. Around the same news
Week In Review The week’s most durable theme is elemental substitution — the systematic replacement of scarce, contested, or environmentally troublesome inputs with things Earth has in bulk. A Tokyo Metropolitan University team published a family of biobased poly(ester amide)s built from inedible plant oils, amino acids, and
Week In Review Longevity science this week continued its measurable pivot from “will it work in mice?” to “what exactly is it doing in humans, and can we prove it with the tools we have?” The clearest signal came from Retro Biosciences, whose CEO Joe Betts-LaCroix reported that the company’
Week In Review The week’s throughline was the shift from AI as generic chatbot to AI as domain-shaped instrument for expert work. Anthropic’s launch of Claude Science is the clearest signal: rather than a new model, the company is betting the wedge into laboratories is a workbench that
Week In Review This was a pivot week for frontier AI: two of the three American labs shipped major releases on June 30, an export-control saga wrapped up in Anthropic’s favor, and the geopolitical center of gravity kept sliding as an open-weight Chinese model climbed the same leaderboards Western
Week In Review The past week made clear that the humanoid-robot conversation has shifted from “when will they be real?” to “who owns the platform stack around them?” On June 30 UBTECH pulled the sheet off the UWORLD U1 series, a full-size, mass-produced “ultra-bionic” humanoid pitched at consumer companionship — a
Week In Review Two decade-defining observatories quietly changed status this week. On July 1 the NSF–DOE Vera C. Rubin Observatory began its ten-year Legacy Survey of Space and Time — the largest coordinated optical survey ever attempted — while three days later a Chinese spacecraft began orbiting an asteroid that may